Current Concepts in the Management of Necrotizing Fasciitis

Frontiers in Surgery

Volumn 1, Issue , 2014, Pages

  Misiakos, Evangelos P ^a   Bagias, George ^a   Patapis, Paul ^a   Sotiropoulos, Dimitrios ^a   Kanavidis, Prodromos ^a   Machairas, Anastasios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Fournier s gangrene; gas gangrene; necrotizing fasciitis; surgical debridement

Indexed keywords

EID: 84939185770     PISSN: None     EISSN: 2296875X     Source Type: Journal    
DOI: 10.3389/fsurg.2014.00036     Document Type: Review

References (82)

1. Levine EG, Manders SM. Life-threatening necrotizing fasciitis. Clin Dermatol (2005) 23:144–7.10.1016/j.clindermatol.2004.06.01415802207
2. Urschel JD, Takita H, Antkowiak JG. Necrotizing soft tissue infections of the chest wall. Ann Thorac Surg (1997) 64:276–9.10.1016/S0003-4975(97)00514-69236387
3. Kaafarani HM, King DR. Necrotizing skin and soft tissue infections. Surg Clin North Am (2014) 94:155–63.10.1016/j.suc.2013.10.011
4. Descamps V, Aitken J, Lee MG. Hippocrates on necrotising fasciitis. Lancet (1994) 344:556.10.1016/S0140-6736(94)91956-9
5. Pouteau C. Mémoire ou recherches sur les symptômes de la gangrene humide des Hôpitaux. In: Poueau C, editor. uvres posthumes. (Vol. 3), Paris: Ph-D Pierres (1783). p. 239–68.
6. Jones J. Surgical Memoirs of the War of the Rebellion: Investigation Upon the Nature, Causes and Treatment of Hospital Gangrene as Prevailed in the Confederate Armies 1861-1865. New York, NY: US Sanitary Commission (1871).
7. Fournier JA. Gangrene foudroyante de la verge. Med Pract (1883) 4:589–97.
8. Brewer GE, Meleney FL. Progressive gangrenous infection of the skin and subcutaneous tissues, following operation for acute perforative appendicitis: a study in symbiosis. Ann Surg (1926) 84:438–50.10.1097/00000658-192684030-00017
9. Wilson B. Necrotizing fasciitis. Am Surg (1952) 18:416–31.
10. Stevens DL, Tanner MH, Winship J. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med (1989) 321:1–7.10.1056/NEJM1989070632101012659990
11. Kaul R, McGeer A, Low DE, Green K, Schwartz B. Population based surveillance for group A streptococcal necrotizing fasciitis: clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. Am J Med (1997) 103:18–24.10.1016/S0002-9343(97)00160-5
12. Goh T, Goh LG, Ang CH, Wong CH. Early diagnosis of necrotizing fasciitis. Br J Surg (2014) 101:119–25.10.1002/bjs.9371
13. Anaya DA, Dellinger EP. Necrotizing soft-tissue infection: diagnosis and management. Clin Infect Dis (2007) 44:705–10.10.1086/51163817278065
14. Schecter W, Meyer A, Schecter G. Necrotising fasciitis of the upper extremity. J Hand Surg (1982) 7:15–9.10.1016/S0363-5023(82)80006-3
15. Eke N. Fournier’s gangrene: a review of 1726 cases. Br J Surg (2000) 87:718–28.10.1046/j.1365-2168.2000.01497.x
16. Anaya DA, McMahon K, Nathens AB. Predictors of mortality and limb loss in necrotizing soft tissue infections. Arch Surg (2005) 140:151–7.10.1001/archsurg.140.2.15115723996
17. Espandar R, Sibdari SY, Rafiee E, Yazdanian S. Necrotizing fasciitis of the extremities a prospective study. Strategies Trauma Limb Reconstr (2011) 6:121–5.10.1007/s11751-011-0116-1
18. Park K, Jung S, Jung Y, Shin J, Hwang J. Marine bacteria as a leading cause of necrotising fasciitis in coastal areas of South Korea. Am J Trop Med Hyg (2009) 80:646–50.19346393
19. Roje Z, Roje Z, Matic D, Librenjak D, Dokuzovic S, Varvodic J. Necrotizing fasciitis: literature review of contemporary strategies for diagnosing and management with three case reports: torso, abdominal wall, upper and lower limbs. Word J Emerg Surg (2011) 23(6):46.10.1186/1749-7922-6-46
20. Martinschek A, Evers B, Lampl L, Gerngroß H, Schmidt R, Sparwasser C. Prognostic aspects, survival rate, and predisposing risk factors in patients with Fournier’s gangrene and necrotizing soft tissue infections: evaluation of clinical outcome of 55 patients. Urol Int (2012) 89:173–9.10.1159/00033916122759538
21. Yeung YK, Ho ST, Yen CH, Ho PC, Tse WL, Lau YK, et al. Wong factors affecting mortality in Hong Kong patients with upper limb necrotising fasciitis. Hong Kong Med J (2011) 17:96–104.21471588
22. Clayton MD, Fowler JE, Jr Sharifi R, Pearl RK. Causes, presentation and survival of fifty-seven patients with necrotizing fasciitis of the male genitalia. Surg Gynecol Obstet (1990) 170:49–55.2294630
23. Green JR, Dafoe DC, Raffin TA. Necrotizing fasciitis. Chest (1996) 110:219–28.10.1378/chest.110.1.2198681631
24. Kalaivani V, Hiremath BV, Indumathi VA. Necrotising soft tissue infection-risk factors for mortality. J Clin Diagn Res (2013) 7:1662–5.10.7860/JCDR/2013/5535.324024086868
25. Elliott DC, Kufera JA, Myers RA. NSTI-risk factors for mortality and strategies for management. Ann Surg (1996) 224:672–83.10.1097/00000658-199611000-000118916882
26. Sorensen MD, Krieger JN, Rivara FP, Klein MB, Wessells H. Fournier’s gangrene: management and mortality predictors in a population based study. J Urol (2009) 182:2742–7.10.1016/j.juro.2009.08.05019837424
27. Rea WJ, Wyryck WJ, Jr. Necrotizing fasciitis. Ann Surg (1970) 172:957.10.1097/00000658-197012000-00005
28. Morua AG, Lopez JA, Garcia JD, Montelongo RM, Guerra LS. Fournier’s gangrene: our experience in 5 years, bibliographic review and assessment of the Fournier’s gangrene severity index. Arch Esp Urol (2009) 62:532–40.19815967
29. Czymek R, Frank P, Limmer S, Schmidt A, Jungbluth T, Roblick U, et al. Fournier’s gangrene: is the female gender a risk factor? Langenbecks Arch Surg (2010) 395:173–80.10.1007/s00423-008-0461-9
30. Benjelloun el B, Souiki T, Yakla N, Ousadden A, Mazaz K, Louchi A, et al. Fournier’s gangrene: our experience with 50 patients and analysis of factors affecting mortality. World J Emerg Surg (2013) 8:13.10.1186/1749-7922-8-1323547796
31. Angoules AG, Kontakis G, Drakoulakis E, Vrentzos G, Granick MS, Giannoudis PV. Necrotising fasciitis of upper and lower limb: a systematic review. Injury (2007) 38(Suppl 5):19–26.18048033
32. Sudarsky LA, Laschinger JC, Coppa GF, Spencer FC. Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg (1987) 206:661–5.10.1097/00000658-198711000-000183314752
33. Ruiz-Tovar J, Córdoba L, Devesa JM. Prognostic factors in Fournier gangrene. Asian J Surg (2012) 35:37–41.10.1016/j.asjsur.2012.04.006
34. Huang KF, Hung MH, Lin YS, Lu CL, Liu C, Chen CC, et al. Independent predictors of mortality for necrotizing fasciitis: a retrospective analysis in a single institution. J Trauma (2011) 71:467–73.10.1097/TA.0b013e318220d7fa21825948
35. Morgan MS. Diagnosis and management of necrotising fasciitis: a multiparametric approach. J Hosp Infect (2010) 75:249–57.10.1016/j.jhin.2010.01.02820542593
36. Weiss KA, Laverdière M. Group A Streptococcus invasive infections: a review. Can J Surg (1997) 40:18–25.9030079
37. Souyri C, Olivier P, Grolleau S, Lapeyre-Mestre M. French network of pharmacovigilance centres. Severe necrotizing soft-tissue infections and nonsteroidal anti-inflammatory drugs. Clin Exp Dermatol (2008) 33:249–55.10.1111/j.1365-2230.2007.02652.x18261144
38. Kimura AC, Higa JI, Levin RM, Simpson G, Vargas Y, Vugia DJ. Outbreak of necrotizing fasciitis due to Clostridium sordellii among black-tar heroin users. Clin Infect Dis (2004) 38:87–91.10.1086/38347115127359
39. Gauzit R. Necrotizing skin and soft tissue infections: definitions, clinical and microbiological features. Ann Fr Anesth Reanim (2006) 25:967–70.10.1016/j.annfar.2006.03.01816675192
40. Bakleh M, Wold LE, Mandrekar JN, Harmsen WS, Dimashkieh HH, Baddour LM. Correlation of histopathologic findings with clinical outcome in necrotizing fasciitis. Clin Infect Dis (2005) 40:410–4.10.1086/42728615668865
41. Shimizu T, Tokuda Y. Necrotizing fasciitis. Intern Med (2010) 49:1051–7.10.2169/internalmedicine.49.296420558917
42. Frazee BW, Fee C, Lynn J, Wang R, Bostrom A, Hargis C, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med (2008) 34:139–46.10.1016/j.jemermed.2007.03.04117976799
43. DiNubile MJ, Lipsky BA. Complicated infections of skin and skin structures: when the infection is more than skin deep. J Antimicrob Chemother (2004) 53(Suppl 2):37–50.15150182
44. Sultan HY, Boyle AA, Sheppard N. Necrotizing fasciitis. BMJ (2012) 345:4274.10.1136/bmj.e4274
45. Wang YS, Wong CH, Tay YK. Staging of necrotizing fasciitis based on the evolving cutaneous features. Int J Dermatol (2007) 46:1036–41.10.1111/j.1365-4632.2007.03201.x17910710
46. Dworkin M, Westercamp M, Park L, McIntyre A. The epidemiology of necrotising fasciitis including factors associated with death and amputation. Epidemiol Infect (2009) 137:1609–14.10.1017/S095026880900253219351432
47. Majeski J, Majeski E. Necrotising fasciitis: improved survival with early recognition by tissue biopsy and aggressive surgical treatment. South Med J (1997) 90:1065–8.10.1097/00007611-199711000-000019386043
48. Wong C, Khin L. Clinical relevance of the LRINEC (laboratory risk indicator for necrotizing fasciitis) score for assessment of early necrotizing fasciitis. Crit Care Med (2005) 33:1677.10.1097/01.CCM.0000170199.43624.B8
49. Majeski JA, Alexander JW. Early diagnosis, nutrition support, and immediate extensive debridement improve survival necrotizing fasciitis. Am J Surg (1983) 145:785–7.6344676
50. Mizokami F, Furuta K, Isogai Z. Necrotizing soft tissue infections developing from pressure ulcers. J Tissue Viability (2014) 23:1–6.10.1016/j.jtv.2013.11.00124360717
51. Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (laboratory risk indicator for necrotizing fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med (2004) 32:1535–41.10.1097/01.CCM.0000129486.35458.7D15241098
52. Chao WN, Tsai SJ, Tsai CF, Su CH, Chan KS, Lee YT, et al. The laboratory risk indicator for necrotizing fasciitis score for discernment of necrotizing fasciitis originated from Vibrio vulnificus infections. J Trauma Acute Care Surg (2012) 73:1576–82.10.1097/TA.0b013e318270d76123188248
53. Thomas AJ, Meyer TK. Retrospective evaluation of laboratory-based diagnostic tools for cervical necrotizing fasciitis. Laryngoscope (2012) 122:2683–7.10.1002/lary.2368022996752
54. Wong C, Wang Y. The diagnosis of necrotizing fasciitis. Curr Opin Infect Dis (2005) 18:101–6.10.1097/01.qco.0000160896.74492.ea
55. Monneuse O, Gruner L, Barth X, Malick P, Timsit M, Gignoux B, et al. Gas gangrene of the abdominal wall due to underlying GI pathology: seven cases. J Chir (Paris) (2007) 144:307–12.10.1016/S0021-7697(07)91959-617925736
56. Wang T, Hung CR. Role of tissue oxygen saturation monitoring in diagnosing necrotizing fasciitis of the lower limbs. Ann Emerg Med (2004) 44:222–8.10.1016/j.annemergmed.2004.03.02215332062
57. Nagano N, Isomine S, Kato H, Sasaki Y, Takahashi M, Sakaida K, et al. Human fulminant gas gangrene caused by Clostridium chauvoei. J Clin Microbiol (2008) 46:1545–7.10.1128/JCM.01895-0718256217
58. Marron CD. Superficial sepsis, cutaneous abscess and necrotizing fasciitis. In: Brooks A, Mahoney PF, Cotton BA, Tai N, editors. Emergency Surgery. Oxford, UK: Blackwell Publishing (2010). p. 115–23.
59. Lille ST, Sato TT, Engrav LH, Foy H, Jurkovich GJ. Necrotizing soft tissue infections: obstacles in diagnosis. J Am Coll Surg (1996) 182:7–11.
60. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J (1999) 18:1096.10.1097/00006454-199912000-0001410608632
61. Mulla ZD. Treatment options in the management of necrotising fasciitis caused by group A Streptococcus. Expert Opin Pharmacother (2004) 5:1695–700.10.1517/14656566.5.8.169515264984
62. Naqvi GA, Malik SA, Jan W. Necrotizing fasciitis of the lower extremity: a case report and current concept of diagnoses and management. Scan J Trauma Resusc Emerg Med (2009) 17:28.10.1186/1757-7241-17-2819527519
63. Norrby-Teglund A, Muller MP, McGeer A. Successful management of severe group A streptococcal soft tissue infection using an aggressive medical regimen including intravenous polyspecific immunoglobulin together with a concervative surgical approach. Scand J Infect Dis (2005) 37:166.
64. Kaul R, McGeer A, Norrby-Teglund A. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome; a comparative observational study. Clin Infect Dis (1998) 28:800–7.10.1086/515199
65. Mok MY, Wong SY, Chan TM. Necrotizing fasciitis in rheumatic diseases. Lupus (2006) 15:380–3.10.1191/0961203306lu2314cr16830885
66. Wong KC, Shih CH. Necrotizing fasciitis of the extremities. J Trauma (1992) 32:179–82.10.1097/00005373-199202000-00011
67. Roje Z, Roje Ž, Eterović D, Družijanić N, Petričević A, Roje T, et al. Influence of adjuvant hyperbaric oxygen therapy on short-term complications during surgical reconstruction of upper and lower extremity war injury: a retrospective cohort study. Croat Med J (2008) 49:224–32.10.3325/cmj.2008.2.22418461678
68. Sarani B, Strong M, Pascual J, Schwab CW. Necrotizing fasciitis: current concept and review of the literature. J Am Coll Surg (2009) 208:279–88.10.1016/j.jamcollsurg.2008.10.032
69. Wong CH, Yam AK, Tan AB, Song C. Approach to debridement in necrotizing fasciitis. Am J Surg (2008) 196:19–24.10.1016/j.amjsurg.2007.08.07618614147
70. Brafa A, Grimaldi L, Brandi C, Nisi G, Calabro M, Campa SA, et al. Abdominoplasty as a reconstructive surgical treatment of necrotizing fasciitis of the abdominal wall. J Plast Reconstr Aesthet Surg (2009) 62:136–9.10.1016/j.bjps.2008.07.03119058770
71. Azize KIC, Ylmaz Ali KL. Fournier’s gangrene: etiology, treatment, and complications. Ann Plast Surg (2001) 147:523–7.
72. Andreasen TJ, Green SD, Childers BJ. Massive infectious soft tissue injury: diagnosis and management of necrotizing fasciitis and purpura fulminans. Plast Reconstr Surg (2001) 107:1025–34.10.1097/00006534-200104010-0001911252099
73. Tang WM, Ho PL, Fung KK, Yuen KY, Leong JC. Necrotising fasciitis of a limb. J Bone Joint Surg Br (2001) 83:709–14.10.1302/0301-620X.83B5.1098711476311
74. Wong CH, Chang HC, Pasupathy S, Khin LW, Tan JL, Low CO. Necrotizing fasciitis: clinical presentation, microbiology, and determinants of mortality. J Bone Joint Surg Am (2003) 85:1454–60.12925624
75. Adachi K, Tsutsumi R, Yoshida Y, Watanabe T, Nakayama B, Yamamoto O. Necrotizing fasciitis of the breast and axillary regions. Eur J Dermatol (2012) 22:817–8.
76. Yamasaki O, Nagao Y, Sugiyama N, Otsuka M, Iwatsuki K. Surgical management of axillary necrotizing fasciitis: a case report. J Dermatol (2012) 39:309–11.10.1111/j.1346-8138.2011.01456.x22211460
77. Netscher DT, Baumholtz MA, Bullocks J. Chest reconstruction: II. Regional reconstruction of chest wall wounds that do not affect respiratory function (axilla, posterolateral chest, and posterior trunk). Plast Reconstr Surg (2009) 124:427–35.10.1097/PRS.0b013e3181bf832319952603
78. Silberstein J, Grabowski J, Parsons JK. Use of a vacuum-assisted device for Fournier’s gangrene: a new paradigm. Rev Urol (2008) 10:76–80.18470279
79. Moues CM, van den Bemd GJ, Heule F, Hovius SE. Comparing conventional gauze therapy to vacuum-assisted closure wound therapy: a prospective randomised trial. J Plast Reconstr Aesthet Surg (2007) 60:672–81.10.1016/j.bjps.2006.01.04117485058
80. Lu SL, Tsai CY, Luo YH, Kuo CF, Lin WC, Chang YT, et al. Kallistatin modulates immune cells and confers anti-inflammatory response to protect mice from group A streptococcal infection. Antimicrob Agents Chemother (2013) 57:5366–72.10.1128/AAC.00322-1323959316
81. Nisbet M, Ansell G, Lang S, Taylor S, Dzendrowskyj P, Holland D. Necrotising fasciitis: review of 82 cases in South Auckland. Intern Med J (2011) 47:543–8.10.1111/j.1445-5994.2009.02137.x20002853
82. Dalsgaard A, Frimodt-Moller N, Bruun B, Hoi L, Larsen JL. Clinical manifestations and molecular epidemiology of Vibrio vulnificus infections in Denmark. Eur J Clin Microbiol Infect Dis (1996) 15:227–32.10.1007/BF015913598740858